SUBJECTINDEX ABS-AMI 8080 - Journal of...

8092

8092

8092

8092

8071

8071

8078

8078

8067

8067

8069

8067

8070

8067

8070

8092

8092

8092

8091

8091

8091

ABS -AMI

8080

8080

8079

8094

8094

8094

8094

8094

8086

8086

8086

8086

8086

8086

8086

8086

8086

8086

8086

8086

8064

8064

8064

8064

8064

8064

8064

8064

8064

8064

8064

8064

8095

8095

8073

8073

8057

8057

8057

8057

8057

8088

8088

8054

8054

8054

8080

8068

8080

8080

8068

8080

SUBJECT INDEX

S-i

ABSORPTION

acetylsalicylic acid

gastrointestinal tract

mephenesin influence

sodium salicylate

ACETAZOLAMIDE

anticonvulsant potency

maximal electroshock seizure

ACETYLCHOLINE

atropine inhibition

8070

heart contractile force

high energy phosphates

intestinal motility

intraarterial injection

8069 8070

mammalian striated muscle

mesenteric reflexes

myotonic goat muscle

reflex apnea

super sensitivity

ACETYLSA.LICYLIC ACID

gastrointestinal absorption

mephene sin

plasma salicylate levels

ACTH

abstinence response

human subjects

morphine addiction

urinary 17-ketosteroid

elevation

ADENINE NUCLEOTIDES


heart muscle content

isolated guinea pig atrium

ADRENA.LECTOMYblood pressure

cardiac arrhythmia

cigarette smoke

denervated nictitating

membrane

Su-4029

LADRENERGIC BLOCKADE

dibenamine

dichloroi soproterenol

i soproterenol vasodepressor

effect

phentolamine

positive chronotropic effects

positive inotropic effects

Su-4029 antagonism

sympathomimetic amines

ADRENERGIC BLOCKING AGENTS


mammalian heart

tetrazotized diorthoanisidine

(TDA)

AJMALINE

atrial fibrillation

A-V transmission

bradycardia

8069 functional refractory period

heart-lung preparation

ALCOHOLabrupt cessation

abstinence eLfects

anticonvulsant properties

anticonvulsant tests

chronic administration

CNS depression

hyperexcitabi lity

MES patterns

neurotoxici ty

physical dependence

protective index

seizure thresholds

ALCOHOL, ALLYL

action mechanism

blood concentration

hemoconcentrat ion

hypot ension

metabolism

8091 microquantitation method

oxygen uptake

8078 pharmacodynamics

8078 plasma histamine

8078 tissue slices

tissue swelling

toxicity

ALPHA-LOBELINK

cross-circulation

ventilatory response

8068 ALPHAPRODINE

8068 intestinal motility

leval lorphan antagonism

8068 ALSEROXYLON

8080 antiarrhythmic effect

atrial flutter

auricular fibrillation

quinidine-like activity

ventricular tachycardia

AMINE OXIDASE

hog kidney cortex

mescaline degradation

8088

8088

8088

80938093

8093

8093

8071

8071

8070

8069

8069

8077

8069

8069

8069

8070

8069

8070

8060

3073

8073

8085

8073

8073

8073

8073

8085

8084

8085

8085

8073

8060

8060

8062

8062

8062

8062

8062

8062

8062

8062

8078

8078

8078

8078

8057

8057

8052

8052

8071

8071

8072

8071

8072

8072

8072

8072

8072

8072

8072

8072

8072

8097

8097

8097

8081

8081

8057

8057

8069

8059

8053

8069

8070

8069

AMI-ATR

SUBJECT INDEX

VOL. 124

5-2

rabbit liver microsomes

rabbit liver mitochondria

sheep plasma

2 -AMINO-4-2-CRLOROANILINO-

s-TRIAZINE

diuretic effects

electrolyte excretion

intravenous administration

water excretion

AMMONIUM CHLORIDE

anticonvulsant augmenting

effect


ANALGESIC -ANTAGONISTS

analgesics

intestinal motility

ANALGESICS

antagonistic drugs

antagoni St S

denervated intestinal ioops

human subjects

innervated intestinal loops

intestinal loop tone

intestinal motility

intestinal segments

morphine

new morphine derivatives

normorphi ne

postoperative pain

sedative potency

testing method

tremorine

ANAPHYLAXIS

acetylcholine response

antibody-containing cells

histamine response

nonsensitized guinea pigs

nonspecific antigen

organ responses in vitro

sensitized guinea pigs

specific antigen

ANOXIA


heart muscle

high energy phosphate

isolated guinea pig atria

ANTIARRHYTHMICS

ataraxic agents


ANTIBIOTICS

biological disposition

streptovaricin

ANTICHOLINESTERASES

atropine block

atropine inhibition

DFP

8070

enzymatic production

eserine

8070


8070


myotonia congeni ta

organic thiophosphate

conversion 8077

8073 sarin

8073 skeletal muscle

ANTICONVULSANTS

alcohol 8086

carbonic anhydrase

inhibitors

di phenylhydantoin

8072 8086

initial seizure severity


mephobarbi tal

MES test

me santoin

paramethadi one

phenacemi de

phenobarbi tal

recovery time

seizure duration

trimethadione

8086

ANTIHISTAMINICS

chiorpheni ramine

comparative study

optical isomers

ARTERIES, RENAL

renal blood flow

sympathomimetic drug

inj ect ions

ATARAXIC AGENTS

antiarrhythmic effect


ATROPINE


dibromopyruvic acid

DMPP vascular responses

extraocular muscle

goat skeletal muscle


8070

8069

8070

8069

8069

8070

8053

8053

8053

8053

8053

8053

8053

8057

8057

8057

8057

8057

8057

8057

8077

8077

8077

8077

ATR-BRA

8081

8074

8074

8074

8053

8081

8081

8053

8074

8079

8097

8054

8064

8053

8053

8053

8080

8079

8097

8054

8059

8080

8053

8063

8063

8063

8063

8075

8075

8075

8075

8075

8053

8074

8053

8074

8053

8053

8074

8059

8053

8079

8097

8067

8059

8059

8084

8058

8053

8054

8081

8079

8079

8053

8089

8089

8076

8076

SUF,JECT INDEX

S -3

1958


myotonia congenita

nerve stimulation

neuromuscular transmission

relaxation time

ThA vascular responses

AUTONOMIC BLOCKING AGENTS

DMPP vascular actions

TMA vascular actions

AUTONOMIC NERVOUS SYSTEM

DMPP

ganglionic stimulation

peripheral stimulation

TMA

BENACTYZINE


antiveratrinic activity

atrial flutter



toxicity


BENZOTRIAZINE DITHIOPHOSPHORIC

ACID (GUTHION)

anticholinesterase formation

enzymatic oxidation

methylcholanthrene

pretreatment

rat liver microsomes

toxicity

BIOASSAY

minimum error table

parallel line

percent potency estimate

precision level

BISHYDROXYCOUMARIN

hemorrhagic necrosi s

menadione treatment

myocardial damage

vitamin E treatment

vitamin Kl treatment

BLOOD FLOW

atropine pretreatment

cardiac output fractionation

DMPP

estrogens

femoral artery

hexamethonium pretreatment

intestine


isotope tracer technique

kidney

ovariectomized rats

phentolamine pretreatment

renal vascular bed


TMA

uterus

BLOOD PRESSURE

acetyicholine depressor

response

acetyicholine response

adrenal ectomy

allyl alcohol hypotension


azapetine pretreatment

biphasic response

cardiac sympathetic nerve

stimulation

carotid occlusion

chlorpheniramine optical

isomers

cigarette smoke

dibromopyruvic acid


DMPP

8097

epinephrine response 8059

8097

hexamethonium influence

8077 hexamethonium pretreatment

histamine depressor response

histamine response

intraarterial veratridine

levarterenol response

mecamylamine influence


nore thandrol one


pressor response

renal blood flow

sympathornimetic amines

8080 8081

TDA adrenergic blockade

TNA

BRAIN

choline retention

DMAE retention

iproniazid administration

iproniazid concentration

8076

8083

8083

8089

8061

8061

8061

8061

8061

8061

8061

8098

8098

8098

VOL. 124

8066

8078

8078

8066

8067

8068

8054

8054

8054

8059

8067

8059

8054

8067

8067

8084

8058

8058

8059

8068

8054

8058

8067

8080

8078

8078

8080

force 8080

8095

8095

8095

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8082

8082

8082

8082

8082

8097

8059

8050

8059

8059

8097

8087

8087

8087

8068

8068

SUBJECT INDEX

S -4

BRA-CHL

isonicotinic acid

concentration

morphine concentration

morphine tolerance

tracer studies

BRAIN STEM

chl orproma zi ne

evoked potentials

latency

medial reticular formation

pentobarbital

recovery cycle

sciatic nerve stimulation

1 -n-BUTYLAMINO-3 -�-TOLUIDINO-

2-PROPANOL (W-l8l)

convulsion dosage

correlation values

mortality dosage

CALCIUMdichloroi soproterenol



isolated rabbit heart

ventricular contractile

CARBON DIOXIDE

C02 57.-O2 95% inhalation

cross-circulation


CARBON TETRACHLORIDE

choline oxidation in vitro

DPN

DPN-linked dehydrogenases

enzymatic changes

8 -hydroxyquinoline

inhibitory action

liver function

liver mitochondria

magnesium ATP-ase activation

magnesium- di sodium versene

oxidative activity

oxidative phosphorylation

serum GOT activity

tissue cation concentrations

versene protective action

CARBONIC A.NHYDRASE

anticonvulsant inhibitors

brain inhibitor

concentration

plasma inhibitor

concentration

CARDIAC GLYCOSIDES

di gi toxin



intracellular distribution

CARDIOVASCULAR SYSTEM

acetylcholine

alp�ha receptor substance

blood pressure

8059

cardiac oxygen utilization

cigarette smoke

dibromopyruvic acid

1-epinephrine

heart rate

hemodynami c changes


mesenteric reflexes

6-methyl enedihydro-

de soxymorphine

norethandrol one

progesterone

pulse pressure

Su -40 29

TEA pretreatment

testosterone

veratridine

CATECHOL AMINE S

cardiac depletion 8082

ephedrine cardioaccelerator

action


reserpine antiaccelerator

action

reserpine pretreatment

veratramine

CENTRAL NERVOUS SYSTEM

atropine 8059


isomers

EEG activation

levorphanol depression

mephene sin

patellar reflex

stimulant effects

CHELATING AGENTS

carbon tetrachloride

8071 enzymatic changes

liver function

8071 CHLORISONDAMINE

ganglionic blockade

8071 Su-4029 pressor response

8097

8097

8097

8097

8097

8097

8068

8068

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8059

8080

8080

8080

8080

8080

8080

force 8080

8077

8077

8061

8061

8061

8061

8087

8087

8087

8087

8087

8089

8089

8089

8089

8089

8089

8054

8054

8086

8072

8098

8098

8072

8098

8072

8086

8086

8072

8098

8066

8066

8065

8066

8065

8066

8066

8080

8080

8073

8073

1958

SUBJECT INDEX

S-5

CHLORPHENIRAMINE

aerosolized histamine

comparative pharmacology

intravenous histamine

optical isomers

oral antihistamine activity

oral toxicity

therapeutic index

CHLORPROMAZINE

evoked potentials

midbrain reticular formation

recovery cycle


CHOLINE


chelating agents

liver function

oxidase stimulation

oxidation in vitro

CHOLINE-l,2 �T4comparative distribution

dimethylaminoethanol-l,2 Cl4

radioactivity recovery

CHOLINE -METHYL -C14

comparative distribution

dimethylaminoethanol-l ,2 Cl4


CIGARETTE SMOKE


hemodynatnic changes

CONVULSIONS

alcohol

anti convul sant s

dosage changes

drug-induced

MES test

mortality correlation

postictal recovery time

seizure patterns

seizure thresholds

tonic-clonic seizures

vital functions

CORONARY BLOOD FLOW

cigarette smoke

CROSS -C IRCULATION

succinylcholine


CYANIDE


mesenteric reflexes

CHL-DIH

DIBENAMINE

epinephrine pressor response 8068

dl-norepinephrine pressor

response

Su -4029

DIBROMOPYRUVIC ACID

action sites

8097 analgesia

atropine

blood pressure

cardiovascular system

central actions

cholinergic effects

ECG

EEC

EMG

mephenesin antagonism

nerve muscle preparation

patellar reflex

peripheral actions

smooth muscle

toxicity

DICHLOROISOPROTERENOL (DCI)

blood pressure

cardiac adrenergic blockade

cardiac sympathetic nerve

stimulation

heart rate


syinpathomimetic amines


DIETHYLSTILBE STROL

enzyme activity


thiophosphate oxidation 8077

DIGITOXIN

binding distribution in vitro 8066

blood levels 8066

intracellular distribution

in vivo

met aboli te s

radioactive

radioisotopic tracers

8054 serum protein binding

subcellular localization

8095 tissue slices

8095 DICOXIN


8067 positive inotropic effect

8067 DIHYDROCODEINEintestinal motility

levallorphan antagonism

VOL. 124

8072

8086

8072

8086

8064

8088

8077

8087

8087

8087

8087

8064

8077

8051

8087

8088

8087

8087

8051

8087

8077

8088

8064

8091

8091

8082

8082

8080

8082

8082

8082

8080

8080

8080

8080

8079

8078

8078

8067

8067

8079

8080

8080

8074

SUBJECT INDEX

S -6

DIM-EST

DIMETHYLAMINOETHANOL-1 ,2 C14

brain fractions

choline precursor

choline-l,2 C14

choline-methyl -C14

comparative tissue

distribution

liver fractions

protein methionine


respiratory carbon dioxide

urinary excretion

1,1 -DIMETHYL-4-PHENYLPIPER-

AZINIUM (DNPP)


autonomic ganglionic

stimulation

comparative study


hind limb denervation

local vasodilatation

peripheral localization


TMA

vascular actions

DIPHENYLHYDANTOIN

ammonium chloride

pretreatment

anticonvulsant action

hyponatremia


repeated oral administration


sodium chloride pretreatment

DIURETICS

formoguanami ne

related s-triazines

ELECTROCARDIOGRAM

cigarette smoke

norethandrolone

ELECTROMYOGRAM

atropine inhibition


ELECTROSHOCK

alcohol

anti convulsant s

carbonic anhydrase inhibitors

diphenylhydantoin

maximal electroshock seizures

maximal seizure pattern

8089 MES patterns

8089 recovery time

8089 seizure threshold

8089 ENZYMES

allyl alcohol

8089 amine oxidases

8089 anticholinesterase formation

8089 ATP-ase activation

8089 carbon tetrachloride

8089 chelating agents

8089 DPN-linked dehydrogenases

liver dehydrogenases

liver microsomal system

8053 liver microsomes

liver mitochondria

8053 mescaline degradation

8053 oxidative activity

8053 oxidative phosphorylation

8053 papaverine metabolism

8053 serum GOT activity

8053 thiophosphate oxidation

8053 tissue preparations

8053 tissue slices

8053 EOSINOPENIA

human subjects

morphine abstinence

8071 EPHEDRINE

8071 cardiac catechol amine

8071 depletion

8071 cardioaccelerator action

8071 dichloroisoproterenol

8071 heart-lung preparation

8071 reserpine antagonism


8093 sympathomimetic amines

8093 ventricular contractile force

1 -EPINEPHRINE

- dichloro analogue (DCE)


8058 epinephrine-reversal


8070 high energy phosphates

8070 intraarterial injection

mesenteric reflexes

8086 TDA adrenergic blockade

8072 vasopressor effect

8071 ventricular contractile force

8071 ESTROGENS

8071 ethinyl estradiol

EST-HEA

8074

8074

8074

8074

8074

8074

8077

8077

8077

8087

8087

8087

8087

8087

8087

8087

8087

8087

8093

8093

8093

8093

8091

8091

8091

8080

8054

8054

8054

8082

8054

8054

8058

8054

8054

8054

�082

8054

8080

8080

8080

8054

8054

8080

8082

8057

8057

8058

8058

8058

8058

8058

8057

8057

8058

8058

8082

8058

8080

8059

8082

8082

8058

8080

8058

8058

8094

8082

8054

8054

8080

8054

8054

8054

8054

8082

8054

1958SUBJECT INDEX

S-7

intestinal blood flow


ovariectomized rats

renal blood flow

“specific tissue activities”

uterine blood flow

ETHIONINE

liver thiophosphate-oxidizing

enzyme

methylcholanthrene response

thiophosphate susceptibility

ETHYLENEDIAMINE TETRAACETATE

ATP-ase activation



liver mitochondrial function

oxidative activity

oxidative phosphorylation

protective action

serum GOT activity

tissue cation concentrations

FORNOGUANAMINE

diuretic effects

related s-triazines

sodium excretion

water excretion

GONADOTROPIN, CHORIONIC

abstinence response

human subjects

morphine addiction

urinary 17-ketosteroid

elevation

HEART

adrenal denervation

adrenalectomy

adrenergic receptors

arrhythmia


cardiac output

cardiac work

catechol amine depletion

cigarette smoke

coronary A-V oxygen

difference

coronary blood flow


dynamics

ECG

ectopic ventricular systoles

negative chronotropic effects

nicotine

nodal rhythm

nore thandrolone

oxygen utilization

piperoxan pretreatment

rate

8058

re serpine

sinus bradycardia

specific adrenergic blockade

sympathetic nerve stimulation

sympathomimetic atnines

“tobacco angina pectoris”

vagotomy

ventricular contractile force

verat rami ne

HEART ARRHYTHMIA

antiarrhythmic effects

ataraxic agents

auricular flutter

coronary ligation

norethandrolone reversion

procaine amide

progesterone reversion

quini dinerefractory period

testosterone reversion

ventricular origin

HEART, ISOLATED

catechol amine depletion

8091 contractile force

8059

DCI adrenergic blockade

dibromopyruvic acid

ephedrine cardioaccelerator

action


8094

nore thandrol one

perfused rabbit heart

progesterone

rate

8059 8094

rauwolfia alkaloids

8054 reserpine antiaccelerator

8054 action

8082

8058

VOL. 124

8078

8078

8055

8055

8078

8078

8078

8055

8075

8068

8068

8068

8068

8068

8068

8068

8068

8068

8068

8068

8055

8075

8078

8055

8078

8075

8055

8055

8055

8078

8078

8055

8075

8068

8068

8068

8068

8068

8064

8053

8064

8064

8064

8053

8087

8087

8087

8096

8080

8082

8082

8096

8094

8096

8082

8082

8080

8080

8062

8062

8067

8073

8073

8073

8073

8097

8073

8073

8073

8097

SUBJECT INDEX

S-8

HEA-INT


rhythm

8059


testosterone

HEART MUSCLE

adenine nucleotides

anoxia

ATP concentration

calcium concentration

cardiac depressants

cardiac stimulants

contractile force

contraction

dicumarol-induced lesions

ethylenediaminetetraacetic

acid (EDTA)

glycerinated myocardial

fibers

hemorrhagic necrosis


ionic strength


menadione treatment

pH

potassium ion

sodium ion

spontaneous failure

stimulation frequency

tension generation

vitamin K1 treatment

HEART RATE

cardiac catechol amine

depletion

cardiac norepinephrine

depletion


ephedrine accelerator action

heart -lung preparation

8094 8096


rauwolfia alkaloids

reserpine acceleration

reserpine antiaccelerator

potency



theophyl line

HEXAHYDRO-l -AZEPINEPROPION-

AMIDOXINE (SU-4029)

action mechanisms

adrenal ect omy

alpha receptor substance

amphetamine pressor response

8080 blocking effects

8058 cardiovascular system

chlori sondamine

C-O pressor response

denervated nictitating

membrane

dibenamine

epinephrine pressor response

iproniazid pretreatment

isopropylarterenol depressor

action 8068

dl-norepinephrine pressor

response

8055 phentolamine

pressor action

sympathomimetic pressor

amine s

tyramine pressor response

HEXAMETHONIUM

allyl alcoholDMPP vascular responses

oxygen uptake

protective action

tissue slices

TMA vascular responses

HYDROCARBONS, HALOGENATED

chelating agents

enzymatic changes

liver function

1-3 -HYDROXY-N-ALLYLMORPHINAN

8082 (LEVALLORPHAN)

metabolic fate 8090

ILEUN

antigen reactions in vitro


INTESTINAL MOTILITY

acetylcholine

analgesic -antagoni sts

analgesicsat ropine

barium response


isomers

DMPP

hexame thoni urn

8068 histamine response

histamine spasm

INT-LEV

8073

8067

8067

8073

8084

8067

8073

8067

8067

8067

8074

8074

8074

8074

8076

8076

8076

8076

8076

8076

8076

8076

8076

8079

8068

8080

8080

8067

8081

8080

8067

8081

8081

8081

8068

8079

8080

force 8080

8064

8074

8088

8074

8081

8074

8081

8088

8074

8064

8081

8088

8064

8081

8090

8090

8090

8090

8073

8073

8090

8090

8090

8090

8090

8080

8080

8080

8078

8078

8081

8081

8081

8079

8080

8073

8073

8050

8050

8050

8050

8050

8050

8091

8091

8091

8091

8091

8091

8091

1958

SUBJECT INDEX

S-9

“intestinal bio-dialysate”


mesenteric reflexes

methacholine response


reflex inhibition

serotonin response

splanchnic nerve section

vagotomy

verat ri dine

INTESTINE

blood flow

estrogens


ovariectomized rats

IPRONIAZID

action mechanism

isonicotinic acid formation

nietaboli sm

monoamine oxidase activity

plasma levels

rat tissue distribution

ISONICOTINIC ACID

iproniazid metabolite

plasma levels

tissue distribution

ISOPROTERENOL

depressor potenUation

depressor response

dichloro analogue (DCI)



intravenous injection


mesenteric reflexes

renal artery injection

renal blood flow

renal vasodilator action

Su-4029 augmentation


vasodepressor effect


17 -KETOSTEROID

abstinence response

ACTH effect

eosinophil count

gortadotropin effect

human subjects

morphine addiction

urinary excretion

KIDNEY

allyl alcohol

blood flow

diamine oxidase

estrogens



local action

mescaline degradation

ovariectomized rats

oxygen uptake


tissue preparations

tissue slices

vasomotor responses

LEVALLORPHAN

chromatographic fractionation

conjugation

3-hydroxymorphinan formation

infrared absorption spectra

intestinal motility

1 evorphan

metabolic disposition

metabolism in vitro

metabol i te s

tissue slices

urinary excretion

LEVARTERENOL

blood pressure

8081

dichloro analogue (DCNE)


blockade




renal blood flow

renal vasoconstrictor action


ventricular contractile force

LEVORPHAN

intestinal motility

levallorphan antagonism

LEVORPHANOL


CNS depression

C14O2 elimination

conj ugation

distribution

estimation

myocardi ti s

absorption

8050

8050

8050

8050

8077

8064

8088

8077

8077

8088

8077

8077

8077

8064

8077

8076

8076

8076

8076

8088

8051

8088

8088

8064

8051

8077

8064

8077

8077

VOL. 124

8075

8075

8092

8057

8057

8057

8057

8088

8088

8088

8088

8088

8071

8071

8071

8071

8071

8071

8071

8071

8071

8071

8077

8077

8077

8077

8084

8084

8084

carbonic anhydrase inhibitor


repeated oral administration


sodium chloride pretreatment

3 -METHYLCHOLANTHRENE

ethione pretreatment

liver thiophosphate-oxidizing

enzyme

protein-free diet

thiophosphate susceptibility

6 -METHYLDIHYDRODESOXYMORPHINE

acute toxicity

analgesia

8064 C-I motility

6 -METHYLENEDIHYDRODESOXYMORPHINE

acute toxicity 8084

8084

8084

8084

8084

8084

8084

8084

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8087

8084

8084

SUBJECT INDEX

S-10

LEV -MET

excretion

N-C14 methyl

plasma levels

synthesis

LIVER

age influence

allyl alcohol

amine degradation

carcinogenic hydrocarbons

castrated animals

diamine oxidase

enzyme activity

enzyme synthesis

guthion toxicity

hexamethonium protection

hormone-treated animals



isonicotinic acid

concentration

MAO inhibition

mescaline oxidase

microsomal enzyme system

microsomal fractions

mitochondrial fractions

oxygen uptake

papaverine metabolism

partial hepatectorny

phenoxybenzamine protection

protein-free diet


thiophosphate-oxidizing

enzyme

tissue preparations

tissue slices

water content

LIVER DAMAGE

allyl alcohol

LIVER FUNCTION


inhibition

choline oxidation

DPN


fatty infiltration

8 -hydroxyquinoline

magnesium-disodium versene

mi tochondria

oxidative activity

oxidative phosphorylationversene treatment

8077

8088

8064

8064

MENAD lONE

dicumarol -induced

protective action

MEPHENESIN

sodium salicylate

MEPROBAMATE



toxicity


MESCALINE

amine oxidases

inhibitor pattern

oxidative deamination

tissue preparations

vertebrate species

METHAZOLAMIDE

absorption

ammonium chloride

pretreatment


seizure spread

seizure threshold

anal gesia

cardiovasctilar effect

C-I motility

hypothermia

mi osis

nalorphine reversal

sedation

6 -METHYL -7 -HYDROXYDIHYDRO-

DESOXYMORPHINE

acute toxicity

analgesia

8084

8084

8084

8076

8076

8076

8084

8083

8084

8083

8083

8085

8073

8073

8084

8085

8084

8085

8084

8083

8083

8083

8091

8091

8091

8091

8091

MET-NIC

8070

8056

8059

8059

8059

8069

8056

8059

8070

8069

8056

8056

8059

8059

8059

8059

8059

8059

8084

8073

8084

8073

8052

8069

8069

8069

8054

8054

8054

8098

8098

8054

8067

8067

8067

8098

8067

8068

8068

8068

8084

8084

8084

8070

8069

8070

8059

8070

8069

8059

8069

8070

8069

1958

SUBJECT INDEX

S-ll

C-I motility

6 -METHYLMORPHINE

acute toxicity

analgesia

C-I motility

MONOAMINE OXIDASE

iproniazid

iproniazid metabolism

persistent inhibition

MORPHINE

acute toxicity

analytical method

blood pressure

brain concentration

conj ugat ion

human subjects

intestinal motility

8084

nalorphine antagonism

new derivatives

normorphine comparison

pharmacological studies

postoperative pain

respiratory minute volume

respiratory rate

tissue distribution

tolerance

MORPHINE ADDICTION

abstinence response

ACTH effect

eosinophil count

gonadotropin effect

human subjects

urinary l7-ketosteroid

depression

MORPHINONE

acute toxicity

analgesia

C-I motility

MUSCLE, SKELETAL

acetylcholine

acetyicholine response

action potentials

antagonism

anticholinesterase

potentiation

anticholinesterases

atropine

atropine block

atropine inhibition

cholinergic responses

8084 cholinesterase levels

CO2-bicarbonate medium

denervat ion

dibromopyruvic acid

EMC


8070

isolated rat diaphragm

mephene sin


nerve stimulation

8070

resting potential

tempeure

MUSCLE, SMOOTH

acetylchol me

atropine antagonism

dibromopyruvic acid

intestinal motility

isolated rabbit ileum

neostigmine

NALORPHINE

antagonistic action

intestinal motility

6-methyl enedihydro-

de soxymorphine

morphine

NEPHRECTOMY

streptovaricin elimination

NEUROMUSCULAR JUNCTION


atropine inhibition

8091 intraarterial injection

NICOTINE

cardiac arrhythmia

cardiac dynamics


convulsion dosage

correlation values

ECCintestinal motility


mesenteric reflexes

mortality dosage

reflex apnea

NICTITATING MEMBRANE

acute denervation

adrenal ectomy

chronic denervation

VOL. 124

8061

8061

8061

8086

8098

8098

8098

8086

8086

8086

8086

8086

8086

8064

8064

8064

8064

8053

8068

8068

8068

8053

8078

8078

8078

8088

8092

8076

8076

8076

8092

8088

8092

8078

8078

8058

8058

8058

8058

8077

8077

SUBJECT INDEX

S -12

NIC -PRO

phentolamine

Su -40 29

NOREPINEPHRINE

cardiac depletion

reserpine

dl-NOREPINEPHRINE

dibenamine blockade

phentolamine blockade

pressor action

Su-4029

NORETHANDROLONE

blood pressure

cardiovascular effects

ECG

eurhythmic potency

NORMORPHINE

analgesic potency

human subjects

morphine comparison

postoperative pain

OUABAIN



positive inotropic effect

OXYGEN CONSUMPTION

allyl alcohol

tissue slices

OXYGEN CONSUMPTION, CARDIAC

cardiovascular hemodynamics

cigarette smoke

ECG

nicotine

PAPAVERINE

absorption

enzymatic transformation

estimation

excretion

glucuronide conjugation

human subjects

mammalian species

metabolic fate

phenolic metabolites

physiological disposition

plasma levels

tissue distribution

PENTOBARBITAL

evoked potentials

8068 midbrain reticular formation

8068 recovery cycle


8096 PENTYLENETETRAZOL

8096 alcohol

convulsion dosage

8068 correlation values

8068 mortality dosage

8068 seizure threshold

8068 PHENOBARBITAL

alcohol compari son

8058 anticonvulsant potency

8058 anticonvulsant tests

8058 neurotoxicity

8058 protective index

PHENOXYBENZAMINE

8085 allyl alcohol

8085 oxygen uptake

8085 protective action

8085 tissue slices

PHENTOLAMINE

DMPP vascular responses

epinephrine pressor response

8080 dl-norepinephrine pressor

8080 response

8080 Su-4029 antagonism

TMA vascular responses

8064 PHOSPHATES, ENERGY-RICH

8064 heart contractile force

heart muscle content

8054 isolated guinea pig atria

8054 PLASMA

8054 amine oxidase

8054 gastrointestinal absorption



isonicotinic acid

8051 concentrations

8051 mephenesin influence

8051 mescaline degradation

8051 salicylate levels

8051 POTASSIUM

8051 heart contractile force

8051 high energy phosphates

8051 PROCAINE AMIDE

8051 cardiac arrhythmia

8051 coronary occlusion

8051 norethandrolone

8051 PROGESTERONE


8061 enzyme activity

rat liver inicrosomes

PRO-RES

8065

8065

8065

8065

8065

8065

8057

8057

8057

8057

8057

8094

8094

8094

8094

8094

8094

8094

8094

8067

8067

8067

8067

8067

8067

8057

8057

8094

8094

8057

8094

8057

8094

8071

8082

8057

8057

8057

8094

8082

8096

8096

8071

8094

8094

8082

8096

8071

8082

8096

8057

8082

8096

8057

8067

8064

8095

8095

8095

8097

8095

8095

8067

8067

8067

8067

8067

8067

SUBJECT INDEX

S-13

1958

thiophosphate oxidation

PROTEIN, DIETARY

3 -methylcholanthrene

protein-free diet

thiophosphate-oxidi zing

enzyme synthesis

PROTEIN, SERUM

component composition

digitoxin binding

lipid content globulin

salt fractionation

serum albumin

zone electrophoresis

QUINIDINE


ataraxic agents

atrial flutter



RAUNESCINE

A-V transmission

functional refractory period

heart rate



RAUWOLFIA ALKALOIDS

A-V propagation time

A-V transmission

bradycardia

cardiac catechol-amine

depletion


heart rate


pharmacological groups


reserpine -type

REFLEXES

dibromopyruvic acid

patellar

REFLEXES, MESENTERIC

acetylcholine

afferent pathway

apnea

1-epinephrine

intestinal motility


8077 isoproterenol

mesenteric traction

8077 nicotine

8077 splanchnic nerve section

vagotomy

8077 veratridine

REFRACTORY PERIOD

antiarrhythmic agents

ataraxic agents

A-V propagation time

A-V transmission

cardiac arrhythmia


quinidine

rauwolfia alkaloids

RESERPINE

antagonistic action

antiaccelerator action


atrial flutter


A-V transmission

cardiac catechol depletion

cardioaccelerator action

cumulative action

diphenylhydantoin



heart rate


8094 8096

mammalian heart

methazolamide anticonvulsant

effect

8094 negative chronotropic action

8094 norepinephrine depletion

8094 quinidine-like activity

8094 reserpine pretreatment

8094 8094 8096

8094 right atrial pressure

8094 ventricular tachycardia

RESPIRATION

8059 acetylcholine

8059 allyl alcohol depression

aipha-lobeline

carotid sinus denervation

central mechanisms


isomers

CO2-O2 inhalationcross-circulation

8067

8067

8084

8083

8083

8084

8067

8083

8095

8067

8067

8095

8097

8095

8067

8078

8078

VOL. 124

8052

8052

8052

8052

8052

8052

8052

8052

8052

8078

8078

8078

8078

8098

8098

8098

8095

8095

8095

8095

8080

8080

8079

8080

8081

8080

8078

8080

8078

8068

8081

8081

8081

8068

8081

8081

8079

8081

8056

8056

8062

8062

8094

8094

8094

8092

8098

8092

8063

8063

8063

8063

SUBJECT INDEX

S-14

RES -TEM


mesenteric reflexes

minute volume

morphine administration

morphine tolerance


nicotine

rate changes

rebreathing response

reflex apnea

splanchnic nerve section

succinylcholine

tidal air volume

ventilatory depression

veratridine

RYANODINE



SALICYLATE, SODIUM

gastrointestinal absorption

mephenesin influence

plasma concentration

statistical analysis

SALIVARY GLANDS

dibromopyruvic acid

SEDATIVE AGENTS

6-methyl enedi hydro-

de soxymorphi ne

SEMINAL VESICLES



SERPENTINE

bradycardia

cardiac arrhythmia


SHOCK

allyl alcohol intoxication

STATISTICAL ANALYSIS

dosage changes

drug-induced convulsions

mephenesin-salicylate

absorption

mortality correlation

plasma salicylate levels

STATISTICAL EVALUATION

minimum error table

parallel line bioassay

percent potency estimate

precision level

STREPTOVARIC IN

absorption

biliary excretion


diffusion rate

enzymatic destruction

nephrec t omy

renal excretion

serum levels

tissue distribution

STROPHANTHIN-K




spontaneous heart failure

STRYCHNINE

convulsion dosage

correlation values

mortality dosage

SUCCINYLCHOLINE

cross -circulation

8092 femoral vein injection

8092 intracarotid injection

8092 ventilatory depression

8092 SYMPATHETIC NERVOUS SYSTEM

cardiac nerve stimulation


blockade

SYMPATHOMINETIC AMINE S

8084 amine-TDA complexes

cardiac stimulant action

chemical specificity


blockade


heart rate


pressor response

8064 renal artery injection

renal blood flow

8098 renal vasomotor responses

8098 Su-4O29

systemic depressor effects

systemic pressor effects


urine flow responses

TEMPERATURE

CO2-bicarbonate medium

diaphragm muscle fibers

8058

8077

8077

8077

8069

8069

8069

8060

8060

8060

8060

8060

8060

8060

8093

8093

8093

8093

8093

8093

8086

8086

8086

8086

8086

8068

8068

8062

8074

8074

8074

8074

8062

8062

8062

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8079

8079

8079

8079

8079

8079

8079

8079

8079

8079

8079

8080

8080

8080

8080

8098

8098

8098

8077

8077

8077

8077

8077

8077

SUBJECT INDEX

S-iS

1958

resting potential

TESTOSTERONE


enzyme activity


thiophosphate oxidation

TETRAETHYLANMONIUM

cardiovascular hemodynamics

cigarette smoke

TETRANETHYLANMONIUM


autonomic ganglionic

stimulation

cholinergic effector

stimulation

comparative study

DNPP


hind limb denervation

local vasodilatation

phentolatnine pretreatment

vascular actions

TETRAZOTIZED DIORTHOANISIDINE

(TDA)

acetylcholine

adrenergic blocking action

asphyxial pressor response

blood pressure

C-O pressor response

epinephrine -reversal

histamine

5 -hydroxytryptamine

isolated arterial strips

related compounds


T}LEOPHYLLINE


heart rate


positive inotropic effect

THEPHORIN

convulsion dosage

correlation values

mortality dosage

THIOPHOSPHATES, ORGANIC

anticholinesterase formation

cholinesterase inhibition

enzymatic oxidation

guthion susceptibility


SKF 525A

TEM-VAS

8056 susceptibility 8077

TRANSMISSION, NEUROMUSCULAR

atropine block



TREMORINE

analgesic effect

8054 antagonistic drugs

8054 atropine antagonism

hyoscine antagonism

8053 morphine comparison

nalorphine

8053 testing method

s-TRIAZINES

chemical specificity

crystalluria

diuretic effects

formoguanamine

oral administration

side effects

TRIMETHADIONE

alcohol comparison

anticonvulsant potency

anticonvulsant tests

neurotoxici ty

protective index

TYRANINE

pressor response

Su-4029 antagonism

UTERUS


blood flow

estrogens


ovariectomized rats


VAS DEFERENS



VASOCONSTRICTION

atropine influence

DNPP

femoral arterial blood flow


VASODILATATION, LOCAL

acetylchol me


VOL. 124

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8053

8081

8081

8081

8081

8053

8082

8082

8082

8082

8067

8067

8067

8067

8067

8067

8057

8057

8057

8082

8082

8075

8075

8075

8075

8075

8075

SUBJECT INDEX

S-l6

VAS -VIT

denervated leg

DMPP


histamine


nitroglycerine


TNA

VASOMOTOR RESPONSES

blood pressure

DMPP

femoral blood flow


renal blood flow

renal vascular bed


TMA

VERATRANINE


depletion


negative chronotropic action


VERATRIDINE

blood pressure

heart rate

intestinal motility


mesenteric reflexes

reflex apnea

VERATRINE RESPONSE


benactyzine pretreatment

meprobamat e

VERATRUM ALKALOIDS

cardiac action


content

VITAMIN K, DEFICIENCY

dicumarol -induced

hemorrhagic necrosis

myocardial damage

prevention

VITAMIN K1

dicumarol-induced myocarditis

protective action

Plummer A J

Povalski H

1958

Abdulian D H

Andersen K S

Arora R B

Aviado D M Jr

Axeirod J

Bain J A

Barsky J

Batterman R C

Beck L

Berman E R

Blum B

Briggs F N

Brody T M

Busch H

Cafruny E J

Calvert D N

Carr J J

Chen C

Cherkas M S

Creese R

Daniel A I

de Beer E �J

de Gubareff T

De Kornfeld T J

DeMaar E W J

Dessau F I

Domino E F

Drill V A

DuBois K P

8059

8050

8057

8081

8051

8089

8088

8092

8079

8088

8098

8055

8087

8059

8079

8087

8092

8060

8088

8056

8068

8081

8078

8085

8061

8075

8079

8058

8077

8093

8074

8095

8062

8054

8095

8051

8075

8064

8096

8086

8090

8068

8050

8080

8092

8077

8056

8072

8075

8076

8052

8052

8076

8053

8081

8050

8098

8088

8086

8088

8091

8078

8097

8073

8071

8089

Perkins M E

Pfeiffer C C

8080 Zacks S

8089 Zeller E A

AUTHOR INDEX

A-l

Eisenman A J

Elliott H W

Fingl E

Fouts J R

Fraser H F

Furchgott R F

Covier W M

Gray C W

Gray W D

Croth D P

Harmel M H

Hendrie K H

Hess S

Hine C H

Innes I R

8082 8094

Inscoe J K

Isbell H

Kagawa C M

Kalman S M

Kao F F

Katsh S

Kien C A

King B D

King W M

Klein S

Kodama J K

Kottegoda S R

Krayer 0

8082 8094 8096

Lasagna L

Lasker N

Lipchuck L

8071 8075

McQuarrie D C

Mannering C J

Martin W R

8059 8061Maxwell R A

8091 Mellett L B

8084 Moran N C

Mouratoff G J

Murphy S D

O’Grady J

Okita G T

8065 8066

Okun R

Osterberg A C

8095

8063

8076

8064

8051

8091

Rauh C E

Redfield B C

Riker W K

Roth F E

Saunders P R

Schanker L S

Schneider F

Scholes N W

Sheps M C

Sherrod T R

Shofer R

Siminoff R

Sjoerdsma A

Sloan J

Spratt J L

8065 8066

Stoufer R M

Swinyard E A

8085 Taylor D B

8054 Tedeschi D H

Tsalikis J

tum-Suden C

8069 8070

Udenfriend S

Unna K R

8059 8061

Van Arman C C

8058 8093

Wagner J C

Wallach D P

8075 Waud D R

8094 8096

Weissbach H

8084 Winbury M M

8071 Wnuck A L

Woods L A

VOL. 124

8068

8068

8071

8076

8067

8097

8083

8090

8068

8056

8063

8054

8051

8083

8051

8091

8070

8072

SUBJECTINDEX ABS-AMI 8080 - Journal of...

Documents

Transcript of SUBJECTINDEX ABS-AMI 8080 - Journal of...